The Trump administration’s move to shelve a plan aimed at lowering drug prices, explained
This week, the Trump administration reversed its position on reforming the drug rebate system. Analysts and advocates say there may be better approaches to lower out-of-pocket costs.
Drug company used rap video to push for higher fentanyl doses and sales
The video is the latest eyebrow-raising piece of evidence in the trial, which has put a spotlight on the federal government's efforts to go after those it says are responsible for fueling the deadly drug crisis.
Watch 4:51
How drug companies helped drive the opioid crisis
The abuse of opioids has become a major public health concern; more than 28,000 people died by overdose in 2014. According to reporting by STAT News, drug companies downplayed the addictive effects of opioid drugs in the late 1990s, assuring…
EpiPen drugmaker announces generic version to cost half the price
Identical to the original product -- a pre-filled syringe containing epinephrine, used for life-threatening allergic reactions -- the generic will cost $300 for two.
In the 1980s, a law was passed to persuade pharmaceutical companies to develop drugs for small populations, but now that rule is being used to reclaim old "orphaned" drugs in order to raise prices and profits. Gwen Ifill learns more…
Additional Support Provided By:
